Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Dermatol ; 176(4): 1010-1020, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27501236

ABSTRACT

BACKGROUND: Primary cutaneous marginal zone B-cell lymphoma (PCMZL) has rarely been reported in patients younger than 20 years. OBJECTIVES: To report our experience with PCMZL in the paediatric/adolescent age group. METHODS: Medical records of patients diagnosed with PCMZL before age 20 years and managed at two cutaneous lymphoma clinics in the U.S.A. and Israel from 1992 to 2015 were reviewed. RESULTS: The study group included 11 patients (six girls; median age 16 years, range 6-19·5); 10 had generalized/multifocal (T3) and one had regional/localized (T2) disease. Lesions were located on the limbs in all patients and the trunk in six; two had facial lesions. Staging in all but one was based on whole-body computed tomography or positron emission tomography. Initial management in most patients included nonradiation modalities: one patient with localized disease received intralesional steroids; six patients with multifocal disease received the following: topical/intralesional steroids (n = 3); excision (n = 2); 'watch and wait' (n = 1). No extracutaneous progression was noted during a median follow-up of 5·5 years (mean 7·5, range 0·5-14). At present, five patients are in complete remission. CONCLUSIONS: Based on our data (largest series in the literature with the longest follow-up), the clinicopathological presentation and course of PCMZL in the paediatric/adolescent age group are similar to those in adults. Given the indolent course and the long life expectancy of these young patients, the cumulative risk of imaging studies and the age-related potential toxicity of treatment, especially radiation, should be taken into consideration.


Subject(s)
Lymphoma, B-Cell, Marginal Zone/pathology , Skin Neoplasms/pathology , Administration, Cutaneous , Administration, Oral , Adolescent , Antineoplastic Agents/administration & dosage , Child , Female , Humans , Injections, Intralesional , Lymphoma, B-Cell, Marginal Zone/therapy , Male , Neoplasm Staging , Positron-Emission Tomography , Skin Neoplasms/therapy , Steroids/administration & dosage , Tomography, X-Ray Computed , Watchful Waiting , Young Adult
2.
Eur J Obstet Gynecol Reprod Biol ; 155(2): 199-203, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21194828

ABSTRACT

OBJECTIVES: Vulvovaginal candidiasis is a common infection among women worldwide. According to previous epidemiological studies, Candida albicans is the most common species of Candida. The prevalence of non-Candida species, however, is increasing. Identification of Candida species among the population will not only help health professionals to choose suitable antifungal treatments, but also prevent development of drug resistance. The aim of this study was to identify, using chromogenic agar medium, the Candida species associated with vulvovaginal candidiasis among a sample of the Iranian population. STUDY DESIGN: In a prospective cohort study during a two year period from March 2006 to March 2008, swab samples of vaginal discharge/secretion were taken from 200 patients admitted to the gynecology clinic of Mahdieh Hospital (Tehran, Iran) with a clinical presentation suggestive of vulvovaginal candidiasis. The isolates obtained were cultured on Sabouraud dextrose agar and chromogenic agar medium. Candida species were also identified by germ tube formation in serum, chlamydospore production on Corn Meal Agar and carbohydrate absorption using the API 20C-AUX kit. Participants were asked to complete a questionnaire investigating the risk factors associated with candidiasis. An assessment of the different species of recurrent and non-recurrent candidiasis was also made. Descriptive statistics, chi-square test, and t-test were used to analyze the data. RESULTS: A total of 191 isolates were obtained from 175 vaginal specimens. Candida albicans accounted for 67% of the strains including single and mixed infections. The other identified species were Candida glabrata (18.3%), Candida tropicalis (6.8%), Candida krusei (5.8%), Candida parapsilosis (1.6%), and Candida guilliermondii (0.5%) respectively. Mixed infection with two or more species of Candida was seen in 10.3% of patients. The most common mixed cause was the combination of Candida albicans and Candida glabrata. Participants who were sexually active and those who had orogenital sex were more likely to suffer recurrent vulvovaginal candidiasis. CONCLUSIONS: Candida albicans was the most common cause of recurrent and non-recurrent vulvovaginitis. The second most common species was Candida glabrata. This study suggests CHROMagar method as a convenient and cost effective yet reliable method to isolate the species of Candida especially in cases where more than one species is present.


Subject(s)
Candida/isolation & purification , Candidiasis, Vulvovaginal/epidemiology , Candidiasis, Vulvovaginal/microbiology , Vulvovaginitis/microbiology , Adult , Candida/classification , Candida/growth & development , Candida albicans/classification , Candida albicans/growth & development , Candida albicans/isolation & purification , Candida glabrata/classification , Candida glabrata/growth & development , Candida glabrata/isolation & purification , Female , Humans , Iran/epidemiology , Mycological Typing Techniques , Outpatient Clinics, Hospital , Pigmentation , Prevalence , Prospective Studies , Recurrence , Risk Factors , Surveys and Questionnaires , Vagina/metabolism , Vagina/microbiology , Vaginal Discharge/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...